|
1
|
Morinaga T, Yasuda H, Hashimoto T,
Higashio K and Tamaoki T: A human alpha-fetoprotein
enhancer-binding protein, ATBF1, contains four homeodomains and
seventeen zinc fingers. Mol Cell Biol. 11:6041–6049. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ido A, Miura Y and Tamaoki T: Activation
of ATBF1, a multiple-homeodomain zinc-finger gene, during neuronal
differentiation of murine embryonal carcinoma cells. Dev Biol.
163:184–187. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yasuda H, Mizuno A, Tamaoki T and Morinaga
T: ATBF1, a multiple-homeodomain zinc finger protein, selectively
down-regulates AT-rich elements of the human alpha-fetoprotein
gene. Mol Cell Biol. 14:1395–1401. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miura Y, Tam T, Ido A, Morinaga T, Miki T,
Hashimoto T and Tamaoki T: Cloning and characterization of an ATBF1
isoform that expresses in a neuronal differentiation-dependent
manner. J Biol Chem. 270:26840–26848. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kataoka H, Miura Y, Joh T, Seno K, Tada T,
Tamaoki T, Nakabayashi H, Kawaguchi M, Asai K, Kato T and Itoh M:
Alpha-fetoprotein producing gastric cancer lacks transcription
factor ATBF1. Oncogene. 20:869–873. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cho YG, Song JH, Kim CJ, Lee YS, Kim SY,
Nam SW, Lee JY and Park WS: Genetic alterations of the ATBF1 gene
in gastric cancer. Clin Cancer Res. 13:4355–4359. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun X, Frierson HF, Chen C, Li C, Ran Q,
Otto KB, Cantarel BL, Vessella RL, Gao AC, Petros J, et al:
Frequent somatic mutations of the transcription factor ATBF1 in
human prostate cancer. Nat Genet. 37:407–412. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mori Y, Kataoka H, Miura Y, Kawaguchi M,
Kubota E, Ogasawara N, Oshima T, Tanida S, Sasaki M, Ohara H, et
al: Subcellular localization of ATBF1 regulates MUC5AC
transcription in gastric cancer. Int J Cancer. 121:241–247. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mabuchi M, Kataoka H, Miura Y, Kim TS,
Kawaguchi M, Ebi M, Tanaka M, Mori Y, Kubota E, Mizushima T, et al:
Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates
to the nucleus with runt domain transcription factor 3 (RUNX3) in
response to TGF-beta signal transduction. Biochem Biophys Res
Commun. 398:321–325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nishio E, Miura Y, Kawaguchi M and Morita
A: Nuclear translocation of ATBF1 is a potential prognostic marker
for skin cancer. Acta Dermatovenerol Croat. 20:239–245.
2012.PubMed/NCBI
|
|
11
|
Li M, Zhao D, Ma G, Zhang B, Fu X, Zhu Z,
Fu L, Sun X and Dong JT: Upregulation of ATBF1 by progesterone-PR
signaling and its functional implication in mammary epithelial
cells. Biochem Biophys Res Commun. 430:358–363. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kawaguchi M, Hara N, Bilim V, Koike H,
Suzuki M, Kim TS, Gao N, Dong Y, Zhang S, Fujinawa Y, et al: A
diagnostic marker for superficial urothelial bladder carcinoma:
Lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests
malignant progression. BMC Cancer. 16:8052016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun X, Li J, Dong FN and Dong JT:
Characterization of nuclear localization and SUMOylation of the
ATBF1 transcription factor in epithelial cells. PLoS One.
9:e927462014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kaspar P, Dvoráková M, Králová J, Pajer P,
Kozmik Z and Dvorak M: Myb-interacting protein, ATBF1, represses
transcriptional activity of Myb oncoprotein. J Biol Chem.
274:14422–14428. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miura Y, Kataoka H, Joh T, Tada T, Asai K,
Nakanishi M, Okada N and Okada H: Susceptibility to killer T cells
of gastric cancer cells enhanced by Mitomycin-C involves induction
of ATBF1 and activation of p21 (Waf1/Cip1) promoter. Microbiol
Immunol. 48:137–145. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jung CG, Kim HJ, Kawaguchi M, Khanna KK,
Hida H, Asai K, Nishino H and Miura Y: Homeotic factor ATBF1
induces the cell cycle arrest associated with neuronal
differentiation. Development. 132:5137–5145. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim TS, Kawaguchi M, Suzuki M, Jung CG,
Asai K, Shibamoto Y, Lavin MF, Khanna KK and Miura Y: The ZFHX3
(ATBF1) transcription factor induces PDGFRB, which activates ATM in
the cytoplasm to protect cerebellar neurons from oxidative stress.
Dis Model Mech. 3:752–762. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nojiri S, Joh T, Miura Y, Sakata N, Nomura
T, Nakao H, Sobue S, Ohara H, Asai K and Ito M: ATBF1 enhances the
suppression of STAT3 signaling by interaction with PIAS3. Biochem
Biophys Res Commun. 314:97–103. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ninomiya T, Mihara K, Fushimi K, Kayashi
Y, Hashimoto-Tamaoki T and Tamaoki T: Regulation of the
alpha-fetoprotein gene by the isoforms of ATBF1 transcription
factor in human hepatoma. Hepatology. 35:82–87. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu H, Lee H, Herrmann A, Buettner R and
Jove R: Revisiting STAT3 signaling in cancer: New and unexpected
biological functions. Nat Rev Cancer. 14:736–746. 2014. View Article : Google Scholar : PubMed/NCBI
|
